Simple Summary Mirtazapine, a tetracyclic antidepressant, acts through noradrenergic and
specific serotonergic systems. Consequently, it was recently applied in major depressive …

Risperidone, a second-generation antipsychotic drug used for schizophrenia treatment with
less-severe side effects, has recently been applied in major depressive disorder treatment …

Abstract Treatment with mirtazapine, a widely prescribed antidepressant, has been linked to
weight gain and dyslipidemia. Whether dyslipidemia occurs secondary to increased appetite …

BACKGROUND: Sibutramine is a reuptake inhibitor of 5-hydroxytryptamine and
noradrenaline, being developed as a treatment for obesity. OBJECTIVE: To investigate the …

Antipsychotics, such as risperidone, increase food intake and induce alteration in glucose
and lipid metabolism concomitantly with overweight and body fat increase, these biological …

Purpose Myricetin, a dietary flavonoid, is effective in the treatment of obesity and insulin
resistance by increasing glucose transport and lipogenesis in adipocyte and diminishing …

Obesity, a global epidemic chronic metabolic disease, urgently demands novel therapies. As
an antimalarial drug, quinacrine has not been reported for its anti-obesity effect to our …

Atypical antipsychotics such as risperidone cause drug-induced metabolic syndrome.
However, the underlying mechanisms remain largely unknown. Here, we report a new …

Myricetin is a flavonol highly prevalent in edible vegetables and fruits, with recognized
hypoglycemic and anti-obesity effects, besides great antioxidant capacity. Thus, this study …

Anti‐obesity medications act by suppressing energy intake (EI), promoting energy
expenditure (EE), or both. Metformin (Met) and mirabegron (Mir) cause weight loss by …